Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial

医学 阿司匹林 冲程(发动机) 内科学 危险系数 氯吡格雷 安慰剂 析因分析 子群分析 随机对照试验 置信区间 病理 机械工程 工程类 替代医学
作者
Hang Li,Min Cheng,Ying Gao,Hongyi Yan,Y. Wang,S. Claiborne Johnston,Philip M. Bath,Pierre Amarenco,Yingying Yang,Weiqi Chen,Yongjun Wang,Yuesong Pan,Yilong Wang
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:56 (6): 1376-1387 被引量:3
标识
DOI:10.1161/strokeaha.124.049826
摘要

BACKGROUND: The prevalence of cerebral small vessel disease (CSVD) imaging markers is high, yet their influence on stroke prognosis remains unclear. This study aimed to estimate the effects of CSVD on the efficacy and safety of clopidogrel+aspirin versus aspirin among patients with minor stroke or high-risk transient ischemic attack. METHODS: This was a post hoc subgroup analysis of the INSPIRES trial (Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial Atherosclerosis), which was a double-blind, placebo-controlled, 2×2 factorial, and randomized clinical trial conducted at 222 centers in China from September 2018 to October 2022. Patients were classified into CSVD score 0 to 2 and CSVD score ≥3 groups based on a modified CSVD burden score without microbleeds. The primary efficacy and safety outcomes were stroke recurrence and moderate-to-severe bleeding risk within 90-day follow-up. We used Cox proportional hazards models to test the treatment-by-CSVD group interaction for stroke and bleeding risk. RESULTS: A total of 5126 patients (median age, 65 [57–71] years; 3915 [64.2%] males) were enrolled and 2131 (41.57%) had a modified CSVD score ≥3. Patients with CSVD score ≥3 had numerically higher stroke recurrence rate (9.10% versus 8.05%) and lower risk of moderate-to-severe bleeding (0.56% versus 0.80%) than those with CSVD score 0 to 2 within 90 days. Clopidogrel+aspirin versus aspirin reduced stroke recurrence to a similar relative degree in both CSVD score 0 to 2 (adjusted hazard ratio, 0.78 [95% CI, 0.61–1.01]; P =0.06) and CSVD score ≥3 groups (adjusted hazard ratio, 0.82 [95% CI, 0.62–1.09]; P =0.12) with no evidence of statistical interaction ( P =0.84). Clopidogrel+aspirin versus aspirin increased bleeding risk to a similar relative degree in both CSVD score 0 to 2 (adjusted hazard ratio, 2.83 [95% CI, 1.52–5.27]; P =0.03) and CSVD score ≥3 groups (adjusted hazard ratio, 2.13 [95% CI, 1.08–4.19]; P =0.22) with no statistical interaction ( P =0.68). CONCLUSIONS: In this post hoc subgroup analysis, no significant interaction effect was observed between the antiplatelet treatment and the modified CSVD score, suggesting that clopidogrel+aspirin may not provide a significantly different benefit-risk profile across patients with CSVD score 0 to 2 versus CSVD score ≥3. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03635749.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
一人发布了新的文献求助10
1秒前
LiuShenglan发布了新的文献求助10
3秒前
香蕉觅云的应助被王光宇采纳,获得10
3秒前
秋风的应助被幕后编剧采纳,获得10
4秒前
科目三的应助被风-FBDD采纳,获得10
4秒前
strack完成签到,获得积分10
5秒前
Nole的应助被磕磕采纳,获得30
5秒前
6秒前
彭于晏的应助被dean采纳,获得10
6秒前
夜枭完成签到,获得积分10
6秒前
杨自强完成签到,获得积分10
7秒前
一朵云发布了新的文献求助10
7秒前
JamesPei的应助被一人采纳,获得10
8秒前
Xilli发布了新的文献求助10
9秒前
10秒前
heoouijee完成签到,获得积分20
11秒前
英吉利25发布了新的文献求助10
11秒前
科研通AI2S的应助被柳叶刀采纳,获得10
12秒前
汉堡包的应助被独特手机采纳,获得10
13秒前
体贴千山完成签到,获得积分10
14秒前
14秒前
NN的应助被hohn采纳,获得10
17秒前
shelter完成签到,获得积分10
18秒前
可爱的函函的应助被pp采纳,获得10
18秒前
18秒前
跳跃的谷秋完成签到,获得积分10
18秒前
科研通AI6.4的应助被斯南采纳,获得30
19秒前
19秒前
隐形晓夏完成签到,获得积分10
20秒前
21秒前
21秒前
隐形晓夏发布了新的文献求助10
22秒前
王英俊完成签到,获得积分10
23秒前
小鬼丶发布了新的文献求助10
23秒前
joyyyang发布了新的文献求助10
24秒前
24秒前
nini发布了新的文献求助10
24秒前
xiaodai完成签到 ,获得积分10
24秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188634
求助须知:如何正确求助?哪些是违规求助? 9576342
关于积分的说明 21847026
捐赠科研通 7786653
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360